TrialJournal of neurology2024

Switching from inotersen to eplontersen in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: analysis from NEURO-TTRansform.

Isabel Conceição et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.